Imagine a treatment that slashes your risk of dying from cancer, heart disease and diabetes — one that also fortifies your ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the ...

The team is led by Leanne Li of The Francis Crick Institute in London, England. Her research combines cancer biology and neuroscience to investigate how cancer communicates with peripheral nerves ...

The mechanism for muscle stem cells repair could inspire therapeutics for muscle loss caused by injury, aging and weight-loss medications.

MARCH 4, 2026, NEW YORK - Ludwig Cancer Research is proud to announce that Director of the Oxford Branch of the Ludwig Institute for Cancer Research ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall ...

Ludwig Cancer Research is proud to announce that Director of the Oxford Branch of the Ludwig Institute for Cancer Research Xin Lu and the Institute’s CEO and Scientific Director Chi Van Dang are ...

EXCLUSIVE: Bestselling Essex Serpent author Sarah Perry has written about dying in one of the most remarkable books of the ...

在很多家庭的抗癌剧本里，都有这样一个极度相似的场景：患者查出疾病后，立刻变成了家里的“一级保护动物”。为了不让身体“受累”，家属们往往会达成一种默契的共识——“快躺下休息，别乱动”。